別名（Synonyms）

IL-17B

Accession

Q9UHF5

GeneID

27190

表達系統（Source）

E.coli-derived human IL-17B protein, Gln21-Phe180, with an N-terminal Met.

分子量大小（Molecular Weight）

Approximately 36.5 kDa, a non-disulfide-linked homodimer of two 161 amino acid polypeptide chains.

氨基酸序列(AA Sequence)

MQPRSPKSKR KGQGRPGPLA PGPHQVPLDL VSRMKPYARM EEYERNIEEM VAQLRNSSEL AQRKCEVNLQ LWMSNKRSLS PWGYSINHDP SRIPVDLPEA RCLCLGCVNP FTMQEDRSMV SVPVFSQVPV RRRLCPPPPR TGPCRQRAVM ETIAVGCTCI F

標簽（Tag）

None

外觀（Physical Appearance）

Sterile Filtered White lyophilized (freeze-dried) powder.

純度（Purity）

> 95% by SDS-PAGE and HPLC analyses.

生物活性（Biological Activity）

Fully biologically active when compared to standard. The ED₅₀ as determined by inducing IL-8 secretion of human HepG2 cells is less than 1.0 μg/ml, corresponding to a specific activity of > 1000 IU/mg.

內毒素（Endotoxin）

< 0.1 EU per 1μg of the protein by the LAL method.

制劑（Formulation）

Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4, with 0.1% Tween-20 and 3% Trehalose.

復溶（Reconstitution）

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.